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The aim of the study was to investigate the prevalence of asthma with or without exercise
induced symptoms among elite and elite aspiring swimmers and to compare sport specific exer-
cise provocation with mannitol provocation.
Methods: 101 adolescent swimmers were investigated with mannitol provocation and sport
specific exercise challenge test. Mannitol positivity was defined as either direct FEV1 PD15
(ordinary criteria) or as b2-reversibility 15% after challenge (extended criteria). A direct posi-
tive exercise test was defined as a drop in FEV1 of 10% (ordinary criteria) or a difference in FEV
of 15% either spontaneous, variability, or with b2-agonist, reversibility (extended criteria).
Results: We found a high prevalence of mannitol and/or exercise positivity. Twenty-six swim-
mers were mannitol direct positive and 14 were direct exercise positive using ordinary criteria.
Using extended criteria 43 were mannitol positive and 24 were exercise positive. When
including reversibility and variability to define a positive test the sensitivity for current asthma
with or without exercise induced symptoms increased while the specificity remained roughly
unchanged. Direct positivity for mannitol and exercise poorly overlapped using ordinary
criteria but improved using extended criteria.
Conclusion: We found a high prevalence of asthma among elite swimmers. The use of vari-
ability and reversibility (liability) as additional criteria to define a positive test provided to
our mind relevant information and should be considered.
ª 2011 Elsevier Ltd. All rights reserved.lergy Research Unit, Dept. of Respiratory Medicine & Allergology e Lund, Ska˚ne University Hospital,
2 6845.
.lu.se (L. Bjermer).
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Table 1 Study population.
Swimmers n Z 101
Males/Females, n 55/46
Age, years 16 (14e17)
Weekly training hours 18 (15e20)
>6 years of training, n (%) 88 (87.1)
Doctors diagnosed asthma, n (%) 37 (36.6)
Inhaled b2, n (%) 27 (26.7)
Inhaled corticosteroids, n (%) 17 (16.8)
Allergic asthma, n (%) 15 (14.9)
Atopy (Zpositive skin prick test),
n (%)
54 (53.5)
FEV1, % predicted 112 (104e118)
FVC, % predicted 111 (104e120)
eNO >20 ppb, n (%) 19 (18.8)
eNO, ppb 13 (9e18)
Data expressed as median (IQ range) unless otherwise stated.
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Asthma and allergies are common diseases and have
increased during the last four decades especially among
children and adolescents.1 Strenuous physical exercise on
elite level may represent a risk factor for asthma devel-
opment.2 The degree of risk is intimately connected to the
type of exercise and the environmental factors connected
to the particular form of sport.
It has been shown that swimming represents a significant
risk for asthma development3 and large number of swim-
mers develop increased bronchial hyperresponsiveness to
methacholine.4,5 The chlorinated pools and exposure to
chloramines is believed to be one important pathogenetic
factor and there is a clear association with degree of and
duration of exposure to chloramines and hyper-
responsiveness and inflammation of the lower airways.6,7 It
is also known that swimmers have an increased suscepti-
bility to airborne allergens.8
The diagnosis of asthma in athletes have been under
debate during the last years. The use of indirect tests has
been advocated as it is believed that indirect provocation
tests, in contrast to direct tests like methacholine, better
reflects airway inflammation. On one hand, test sensitivity
and specificity has been questioned, especially as many
athletes that are well controlled with their asthma medi-
cation do not respond to exercise or dry air provocation. On
the other hand, a positive methacholine challenge test does
not predict that the subject necessarily benefit from anti-
asthma treatment. In a study on skiers with asthma symp-
toms and positive methacholine test, three months on
Budesonide (800mg per day) had no effect on the disease.9
Thus asthma in different athletes may have a different
pathophysiology, i.e different endotypes10 and it is thus
necessary to identify those that may benefit from antiin-
flammatory treatment. Exercise challenge test has earlier
been shown to identify exercise-induced asthmatic patients
that benefit from anti-inflammatory treatment. The degree
of fall in the test was proportionate to the inflammation
intensity in induced sputum.11 Recently, mannitol chal-
lenge has been proposed as an alternative indirect test to
confirm the presence of exercise induced asthma12 and
studies of elite summer athletes and skiers have been
performed.13,14 Whether the test is suitable as a diagnostic
tool in all kind of athletes with an aetiology different than
allergy still has to be studied.
The aim of this study was to investigate the prevalence
of asthma with or without exercise induced symptoms in
elite and elite aspiring swimmers. A second aim was to
compare indirect testing with mannitol to a sport specific
exercise challenge test. The aim was also to relate these
results to symptoms and disease history.
Materials and methods
Subjects
In 2008, swimmers were recruited from elite groups in the
southwestern part of Sweden. 101 swimmers, 55 male and
46 female, 13e24 years, training volume 10e30 h/week
were included in the study.(Table 1)Study design
The swimmers were tested at two different days at least
one week apart. During the first day, the subjects answered
a questionnaire and a physical examination including skin
prick test, FENO was done. The mannitol provocation test
was perfomed during the fist test day and the sport specific
exercise test on the second. No asthma medication were
used 24 h before the test days.
Questionaire: The swimmers were asked about presence
of respiratory symptoms, allergic symptoms and life style
factors as previously described.3 The questionaire was self
filled in and complemented by an interview.
Exercise induced symptoms was defined as dyspnoea,
wheezing or severe cough adjacent to physical activity.
Current asthma was defined as report of symptoms such
as wheezing and/or nocturnal symptoms without respira-
tory infection during the past 12 months.
Current asthma with exercise induced symptoms was
defined as current asthma with wheezing or coughing and
chest tightness adjacent to physical activity.
Exacerbations was defined as either emergency room
visits or periods with more accentuated symptoms that
required an increase in medication during the last 12
months.
Current rhinitis was defined as report of symptoms as
sneezing, runny, or blocked nose without concomitant
respiratory infection.
Rhinitis with impact on daily living was defined as
a current rhinitis which affected the swimmers in their
daily lives.
Allergy testing: All subjects were skin prick tested with
a panel of airborn allergens, i.e pollen (birch, timothy, mug-
wort), pets (cat, dog, horse), mould (Claudosporium and
Alternaria) and house dust mite (D. pteronyssinus and D. Far-
inae). A test was considered positive if the weal was 3 mm.
Exhaled Nitric Oxide was measured by a handheld device
(NIOX Mino, Aerocrine, Sweden) according to the ATS and
ERS recommendations with an exhaled flow rate of 50ml/s.15
Mannitol challenge test: The test was performed in
all subjects in the swimming pool arena. Mannitol (Aridol,
Figure 1 Illustration of direct positivity after mannitol
provocation defined as a drop in FEV1 of 15% from baseline
after inhalation of cumulative doses of mannitol  635 mg
(ordinary criteria) vs reversibility defined as an increase 15%
from lowest to highest FEV1 value after inhalation of 1 mg
terbutalin (extended criteria).
Extended diagnostic criteria’s used for indirect challenge testing in elite asthmatic swimmers 17Pharmaxis) was inhaled in incremental doses until
a maximal cumulative dose of 635 mg was reached or a drop
in FEV1 of 15%. A flow-volume spirometry (Spira2000, Fin-
land) was performed at baseline and 60 s after each dose.
After 30 min a new spirometry was done and the swimmers
inhaled terbutaline (1 mg) followed by a spirometry after
another 30 min. A positive test, PD15Mann, was defined as
a drop in FEV1 of 15% of baseline. PD15Mann was defined as
the cumulative dose of mannitol giving rise to a 15% fall in
FEV1. Positive reversibility was defined as an increase in
FEV1 15% compared to FEV1 after provocation.
Exercise challenge test: For the sport specific exercise
test both males and females were swimming 600 m during
6e8 min. During the first 2 min a pulse rate of about 150
was held, and during the remaining 4e6 min a pulse rate
90% of maximal capacity was aimed. The pulse was
checked during the race by a Polar waterproof puls watch
(Polar RS 400) and checked manually after 300 m, 400 m,
500 m and at the end of the test. Flow-volume spirometry
measuring FEV1 and FVC was performed before the start.
FEV1 was measured immediately after finishing the lap
(about 2 min after the exercise) and then 5, 10, 15, and
30 min after the race. The subjects then inhaled 1 mg
terbutaline and a new spirometry was performed after
another 30 min. A positive test was defined as a drop in
FEV1 of 10% from baseline (ZExerc 10%). A positive vari-
ability was defined as drop of FEV1 from the highest FEV1
15% and a positive reversibility was defined as an increase
in FEV1 15% compared with the lowest value after
provocation.
The Trichloramine content of the air was measured16,17
at two different occasions both at 50 cm above water line
and in the surrounding area in the swimming hall.
Statistics
SPSS (SPSS Inc., Chicago, IL) was used for statistical anal-
ysis. All data is given as median (IQR), unless otherwise
stated. Chi-square test was used for group comparisons.
Spearmans correlation was used for relationship between
the various tests concerning both direct fall and revers-
ibility. A p-value of <0.05 (two tailed) was considered
significant.
Results
Study population
Study population is described in Table 1. Thirty-seven of
the swimmers had a doctors diagnosed asthma. Fifty-four
swimmers were skin prick test positive, 13 were positive to
a single antigen and the others had multiple sensitizations.
Swimmers with a training history more than 6 years
were more likely to have a physician diagnosed asthma
(p Z 0.028).
Mannitol provocation test
The mannitol provocation test was performed on all 101
swimmers. Twenty-six subjects had a positive test definedas a drop in FEV1 of 15%. After inhalation of terbutaline,
41 of the swimmers were reversible 15% compared to
their lowest value post mannitol (Fig. 1). When the criteria
for a positive test was extended and defined as a drop of
15% compared to baseline (PD15Mann) and/or a reversibility
in FEV1 of 15% from the lowest to the highest value after
terbutaline post challenge (PD15Mann þ Rev 15%) an addi-
tional 17 swimmers had a positive test, giving a total of 43
swimmers with a positive test with extended criteria
(Table 2).
The swimmers with a positive mannitol provocation test
under ordinary criteria (PD15Mann), had significantly more
current asthma (p Z 0.010), current asthma with exercise
induced symptoms (p Z 0.02) and rhinitis with impact on
daily living (p Z 0.048). When extending the criteria and
comparing swimmers with a positive mannitol provocation
test and/or reversibility (PD15Mann þ Rev 15%) with those
who had a negative test there was a significant difference
in current asthma (p Z 0.008), current asthma with exer-
cise induced symptoms (pZ 0.005) and rhinitis with impact
on daily living (p Z 0.005). Regarding exacerbations and
respiratory symptoms during exercise there were no
significant differences. When using 20% as reversibility as
extended criteria the significance stayed, current asthma
(p Z 0.004), current asthma with exercise induced symp-
toms (p Z 0.004) and rhinitis with impact on daily living
(p Z 0.024) (Table 3).
Exercise challenge test
The exercise test was performed by 97 of the swimmers.
Fourteen subjects had a 10% drop of FEV1 compared to
baseline during the first 30 min after the exercise (Exerc
10%). After inhalation of terbutaline, 17 of the swimmers
improved FEV1 15% compared to their lowest value post
Table 2 Characteristics of the subjects in relation to outcome in mannitol provocation test.
Subjects with: PD15mann
n Z 26
Reversibility 15%
n Z 41
PD15mann and/or
reversibility 15% n Z 43
Exercise induced symptoms n Z 75 21 (28.0) 32 (42.7) 34 (45.3)
Current asthma n Z 60 21 (35.0) 31 (51.7) 32 (53.3)
Current asthma with exercise induced symptoms
n Z 54 19 (35.5) 29 (53.7) 30 (55.6)
Exacerbations n Z 17 5 (29.4) 9 (52.9) 9 (52.9)
FENO >20 ppb n Z 19 6 (31.6) 10 (52.5) 10 (52.6)
Current rhinitis n Z 45 14 (31.1) 19 (42.2) 21 (46.7)
Rhinitis with impact on daily living n Z 38 14 (36.8) 22 (52.9) 23 (60.5)
Data is shown as numbers (%) within each group.
Current asthma; defined as report of symptoms such as wheezing and/or nocturnal symptoms without respiratory infection during the
past 12 months.
Current asthma with exercise induced symptoms; defined current asthma with respiratory symptoms (wheezing, cough and chest
tightness) adjacent to physical activity.
Exacerbations; defined as either emergency room visits or periods with more accentuated symptoms that required an increase in
medication.
Current rhinitis; defined as report of symptoms as sneezing, runny, or blocked nose without concomitant respiratory infection.
Rhinitis with impact on daily living; a current rhinitis which affected the swimmers in their daily lives.
18 K. Romberg et al.exercise (referred to as reversibility, Fig. 2). Six of the
swimmers had a higher FEV1 just after the exercise test and
then dropped 15% compared to the highest value
(referred to as variability, Fig. 2). When criteria for a posi-
tive test was extended and defined as either a drop of 10%
compared to baseline, and/or a reversibility and/or vari-
ability of 15% (Exerc 10% þ Rev 15%), a total of 24 subjects
had a positive challenge test (Table 4).
When comparing the swimmers with a positive exer-
cise (Exerc 10%), ordinary criteria, with the swimmers who
had a negative test there were no significant differencesTable 3 Characteristics of subjects with a positive mannitol p
criteria.
Subjects with: All swimmers
n Z 101
Mannitol nega
ordinary criter
n Z 75
Exercise induced symptoms, n (%) 75 (74.3) 54 (72.0)
Current asthma, n (%) 60 (59.4) 39 (52.2)
Current asthma with exercise
induced symptoms, n (%)
54 (53.5) 35 (46.7)
Exacerbations, n (%) 17 (16.8) 12 (16.0)
Current rhinitis, n (%) 45 (44.6) 31 (41.3)
Rhinitis with impact on
daily living, n (%)
38 (37.6) 24 (32.0)
Current asthma; defined as report of symptoms such as wheezing and
past 12 months.
Current asthma with exercise induced symptoms; defined current ast
tightness) adjacent to physical activity.
Exacerbations; defined as either emergency room visits or periods
medication. Current rhinitis; defined as report of symptoms as sne
infection.
Rhinitis with impact on daily living; a current rhinitis which affected
Extended criteria; is defined as PD15 positive and/or reversibility 1between the groups. When comparing swimmers with
a positive exercise test due to extended criteria with those
who had a negative test, there was a significant difference
for current asthma (pZ 0.026) and for current asthma with
exercise induced symptoms (p Z 0.007) but no other
significant difference.(Table 5)
When using reversibility 20% instead of 15% as extended
criteria, there was no significant difference for current
asthma between the swimmers with only a direct fall (Exerc
10%) to those who had a positive test due to extended
criteria (Exerc 10% þ Rev 20%).rovocation test at ordinary criteria compared with extended
tive
ia
Mannitol negative
extended criteria
n Z 58
Mannitol positive
ordinary criteria
n Z 26
Mannitol positive
extended criteria
n Z 43
41 (70.7) 21 (80.8) 34 (79.1)
28 (48.3) 21 (80.8) 32 (74.4)
24 (41.4) 19 (73.1) 30 (69.8)
8 (13.8) 5 (19.2) 9 (20.9)
24 (41.4) 14 (53.8) 21 (48.8)
15 (25.9) 14 (53.8) 23 (53.5)
/or nocturnal symptoms without respiratory infection during the
hma with respiratory symptoms (wheezing or coughing and chest
with more accentuated symptoms that required an increase in
ezing, runny, or blocked nose without concomitant respiratory
the swimmers in their daily lives.
5%.
Figure 2 Illustration of direct positivity after exercise chal-
lenge defined as a drop in FEV1 of 10% from baseline (Exerc
10%; ordinary criteria). Reversibility; an increase 15% from
lowest to highest FEV1 value after inhalation of 1 mg terbuta-
line and variability; a drop 15% from highest to lowest FEV1
value (extended criteria).
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clinical characteristics (Fig. 3)
When using ordinary criteria to define a positive test
(PD15Mann) the sensitivity of the test for detecting
current asthma and asthma with exercise induced symptomTable 4 Characteristics of the subjects in relation to outcome
Subjects with: Exercise positive
n Z 14
Exercise induced symptoms
n Z 73
11 (15.1)
Current asthma n Z 58 10 (17.2)
Current asthma with exercise
induced symptoms n Z 54
9 (17.0)
Exacerbations n Z 17 4 (23.5)
FENO>20 ppb n Z 19 1 (5.3)
Current rhinitis n Z 45 8 (18.6)
Rhinitis with impact on daily
living n Z 36
6 (15.8)
Data is shown as numbers (%) within each group.
Current asthma; defined as report of symptoms such as wheezing and
past 12 months.
Current asthma with exercise induced symptoms; defined current ast
tightness) adjacent to physical activity.
Exacerbations; defined as either emergency room visits or periods
medication.
Current rhinitis; defined as report of symptoms as sneezing, runny, o
Rhinitis with impact on daily living; a current rhinitis which affectedwas 35.0 and 35.2. When using extended criteria
(PD15Mann þ Rev 15%) the sensitivity increased to 53.3 and
61.1. The specificity drops for current asthma from 80.8 to
74.4 and nothing at all for asthma with exercise induced
symptoms. When comparing ordinary (PD15Mann) to
extended criteria (PD15Mann þ Rev 15%) the sensitivity for
exacerbations increased from 29.4 to 53.0. The specificity
was low and increased from 19.2 to 20.9.
For detecting current rhinitis the sensitivity of the test
was low 31.1 with ordinary criteria and increased to 46.7
when using extended criteria while the specificity dropped
from 53.9 to 48.8. For detection of rhinitis with impact on
daily living the sensitivity of the test was also low 36.8
when using extended criteria (PD15Mann þ Rev 15%) the
sensitivity increased to 60.5 and the specificity remained
the same.
The sensitivity for detecting a FENO-value 20 was
increased from 31.6 to 52.6 when using extended criteria
instead of ordinary criteria while the specificity stayed the
same. Using reversibility 20% instead of 15% made only
marginal difference in specificity but lowered the sensi-
tivity in all parameters.
Sensitivity and specificity of exercise test (Fig. 4)
When using ordinary criteria to define a positive test (Exerc
10%) the sensitivity of the test for detecting current asthma
and current asthma with exercise induced symptoms was
even lower 17.2 and 17.0. When using extended criteria
(Exerc 10% þ Rev 15%) the sensitivity increased to 32.8 and
32.1 while the specificity increased for current asthma from
66.7 to 79.2 and for asthma with exercise induced symp-
toms from 64.3 to 70.8.
Both the sensitivity and specificity for exacerbations
were low and using extended criteria made no significant
difference. The sensitivity for the tests increased from
23.5 to 29.4 while the specificity dropped from 28.6 toin exercise provocation test.
Reversibility 15%
n Z 17
Exerc 10% and/or
reversibility 15% n Z 24
15 (20.5) 20 (27.4)
14 (24.1) 19 (32.8)
13 (24.5) 17 (32.1)
4 (23.5) 5 (29.4)
3 (15.8) 4 (16.7)
8 (18.6) 12 (27.9)
7 (18.4) 10 (26.3)
/or nocturnal symptoms without respiratory infection during the
hma with respiratory symptoms (wheezing or coughing and chest
with more accentuated symptoms that required an increase in
r blocked nose without concomitant respiratory infection.
the swimmers in their daily lives.
Table 5 Characteristics of subjects with a positive exercise provocation test ordinary criteria compared with extended
criteria.
Subjects with: All swimmers
n Z 101
Exercise negative
ordinary criteria
n Z 83
Exercise negative
extended criteria
n Z 73
Exercise positive
ordinary criteria
n Z 14
Exercise positive
extended criteria
n Z 24
Exercise induced symptoms,
n (%)
75 (74.3) 62 (74.2) 53 (72.6) 11 (78.6) 20 (83.3)
Current asthma, n (%) 60 (59.4) 48 (57.8) 39 (53.4) 10 (71.4) 19 (79.2)
Current asthma with exercise
induced symptoms, n (%)
54 (53.5) 36 (43.4) 44 (60.3) 9 (64.3) 17 (70.8)
Exacerbations, n (%) 17 (16.8) 13 (15.7) 12 (16.4) 4 (28.6) 5 (20.8)
Current rhinitis, n (%) 45 (44.6) 35 (42.2) 31 (42.5) 8 (57.1) 12 (50.0)
Current rhinitis with impact on
daily living, n (%)
38 (37.6) 30 (36.1) 26 (35.6) 6 (42.9) 10 (41.7)
Current asthma; defined as report of symptoms such as wheezing and/or nocturnal symptoms without respiratory infection during the
past 12 months.
Current asthma with exercise induced symptoms; defined current asthma with respiratory symptoms (wheezing or coughing and chest
tightness) adjacent to physical activity.
Exacerbations: defined as either emergency room visits or periods with more accentuated symptoms that required an increase in
medication.
Current rhinitis; defined as report of symptoms as sneezing, runny, or blocked nose without concomitant respiratory infection.
Rhinitis with impact on daily living; a current rhinitis which affected the swimmers in their daily lives.
Extended criteria; defined as Exercise 10% drop and/or reversibility 15% and/or variability of 15.
20 K. Romberg et al.20.8. For detection of current rhinitis and rhinitis with
impact on daily living both the sensitivity and specificity
were low, 18.6 and 57.1 respectively 16.7 and 42.9, and
increased only marginally when using the extended
criteria.
The sensitivity, 5.3 and specificity, 7.1 for detecting
a FENO-value 20 were very low in the exercise test.
When using extended criteria the values were still very
low but increased to 16.7 for sensitivity and 21.1 for
specificity.
Using reversibility 20% instead of 15% as extended
criteria made no difference compared to using reversibility
15% in any of the parameters.Figure 3 Sensitivity and specificity when different crMannitol vs exercise challenge (Fig. 5)
Ninety-seven of the 101 subjects performed both provoca-
tion tests. When using the ordinary criteria (PD15Mann and
Exerc 10%) only five of the swimmers were positive in both
tests (Fig. 5a). When using extended criteria
(PD15Mann þ Rev 15% and Exerc 10% þ Rev 15%), 14 of the
swimmers were positive in both tests (Fig. 5b). When using
ordinary criteria for both tests (PD15Mann þ Exerc 10%), 34
of the swimmers with current asthma were not identified
(Fig. 5c). Eight of those were on regular treatment with ICS.
Nine of the swimmers had a positive test (five in mannitol
provocation test and four in exercise test) withoutiteria were used to define a positive mannitol test.
Figure 4 Sensitivity and specificity when different criteria were used to define a positive exercise test.
Extended diagnostic criteria’s used for indirect challenge testing in elite asthmatic swimmers 21having current asthma. When using extended criteria
(PD15Mann þ Rev 15% and Exerc 10% þ Rev 15%) among
subjects with current asthma, 14 were positive in both
tests, and 21 current asthma subjects were not identified
(Fig. 4d). Also in this group eight were treated with ICS
regularly, and 15 of 53 with a positive test did not have
current asthma.
There was a significant correlation between PD15Mann
value and the degree of reversibility in both mannitol
provocation test (p < 0.001, r Z 0.525) and exercise test
(p Z 0.035, r Z 0.216) among all the swimmers. The FEV1
drop in the exercise test also had a significant correlation to
the degree of reversibility in the exercise test (p < 0.001,
r Z 0.492), but not in the mannitol provocation test
(p Z 0.12). However, there was a significant correlation
between the degree of reversibility in the mannitol provo-
cation test and degree of reversibility in the exercise test
(p Z 0.003, r Z 0.298).Relation to atopy
In the exercise test nine out of fourteen who were
positive with ordinary criteria were atopic and with
extended criteria the number was 16 out of 24. In the
mannitol test there were no significant difference in
atopy, for ordinary criteria, 14 out of 26 and for extended
criteria 25 out of 43 were atopic. The swimmers with
a positive skin prick test had a significant higher FENO
level (p Z 0.021).Trichloramine measurement
The trikloramine measurement were independent of if the
measurements were made just above the water surface or
if they were taken at some distance from the poolside.
The values were also similar when comparing the test
day (330, 290 ug/m3) to a normal training day (320,
300 ug/m3).Discussion
The main finding in this study is the high frequency of
positive provocation tests, more frequent for the mannitol
provocation test than for the exercise test. Despite the
relatively high frequency of positive tests many of the
swimmers with asthma symptoms were test negative when
ordinary criteria for mannitol provocation test and a drop of
FEV1 10% for exercise provocation test were used. This is
also in line with findings from others showing a discrepancy
between exercise induced respiratory symptoms and posi-
tive indirect testing.18,19
The swimmers have a high frequency of asthma as
previously shown (3). One underlying cause could be chlo-
ramine. In our study all the swimming pools were chlori-
nated and the swimmers spent a lot of time in this special
environmental also besides training hours. The quality of
the air in the swimming pool arena together with the
hyperventilation during long training sessions leads to
a great burden on the respiratory epithelium. Exposure to
a chlorinated pool environment is known to increase the
risk of asthma development (6). Trichloramine, a highly
volatile product, reacts with the respiratory epithelium
disturbing the integrity of the respiratory mucosa.20 This is
indicated by reduced serum Clara Cell protein (CC16) levels
which has been reported not only from active swimmers,
but also pool-workers spending their time in the pool
arenas.21 In a previous paper we have discussed the
increased excretion of Clara cells protein during exercise
test suggesting an epithelial stress not found during the
mannitol provocation test.22
Earlier studies have previous shown a mismatch between
reported symptoms of breathing problems related to
exercise and outcome of challenge tests under laboratory
conditions.23,24 Contributing factors to this could be diffi-
culty to reach sufficient load during the tests due to both
poor running technique and the athlete’s high level of
fitness. The environment in which tests are performed is
also not consistent with the athlete’s training surroundings
and may also influence the results.
Figure 5 Number of provocation test positive subjects among 97 tested swimmers where different criterias were used for to
define a positive test. (a,c) Ordinary criteria; PD15Mann defined as a drop in FEV1 of 15% from baseline after inhalation of
cumulative doses of mannitol  635 mg. Exerc 10% defined as a drop in FEV1 of 10% from baseline after exercise challenge. (b,d)
Extended criteria with mannitol provocation test; defined as PD15Mann positive and/or reversibility 15%, exercise provocation
test; defined as Exerc10 and/or reversibility 15% and/or variability of 15%. (a,b) in all swimmers, (c,d) in subjects with current
asthma, defined as report of symptoms such as wheezing and/or nocturnal symptoms without respiratory infection during the past
12 months.
22 K. Romberg et al.Our goal of this study was to conduct exercise tests in
the swimmers training environment and compare it with
a mannitol provocation a challenge test that is easy to
conduct in primary care settings and does not require
expensive investments. The mannitol provocation test has
the advantage of being a standardized test and easy to
perform. However, it might have the disadvantage that it
does not take into account the athlete special environ-
ment, which is however done in this study.
In our study both the exercise and the mannitol provo-
cation showed little overlap with reported exercise induced
respiratory symptoms (EIS). This is also in agreement with
other studies. In a study by Parson on 107 college athletes
they found 39% hade a positive EIB response after eucapnic
hyperventilation (EVH). No association was found between
EIS and EIB in there study.19 One contributing factors to
these observations could be that the symptoms reported
are not only caused by asthma but also due to other causes
such as exercise induced laryngeal obstruction (EILO),
hyperventilation and training above or at their maximum
capacity.25 In both tests the conformity was better both for
current asthma and current asthma with exercise induced
symptoms.The exercise test in our study showed, compared to the
mannitol test, lower frequency of positive exercise test,
defined as exercise induce bronchoconstrion (EIB), and less
consistency with current asthma and current asthma with
exercise induced symptoms. One explanation is the
favourable environment in the swimming pool area. It is
well established that inhalation of warm moist air protects
against bronchoconstriction.26 Other explanations may be
the breathing pattern. Some of the swimmers had a some-
what different lung function response after the exercise
test, compared to what is usually seen after a common
treadmill provocation. Some swimmers do not hyperventi-
late during their training or race. The breathing pattern is
more like intermittent deep inspirations and they start to
hyperventilate after exercise. Fifty-four of the swimmers
had a FEV1 higher after provocation, median 7.5 (IQR
4e12), giving rise to a variability but only one had a vari-
ability >15% without having a reversibility >15%. When
performing the test in the pool there is a difficulty in
obtaining sufficiently high work load and keep it for
a sufficiently long time. When interviewing the swimmers,
they reported they often use their legs only during the
start, the turns and finish, even during competition, not to
Extended diagnostic criteria’s used for indirect challenge testing in elite asthmatic swimmers 23get to much lactic acid, and might therefore not get suffi-
ciently high load due to using mainly their arms during the
test. We aimed to ensure a sufficient a work load by using
Polar waterproof pulse watch during the race and regu-
larly checking pulse rate each 100 m. Seventy-five procent
of the swimmers reached 90% of their HRmax or more
(median 190, IQR184,195).
Both the mannitol tests and especially the exercise test
showed a low sensitivity to detect swimmers with asthmatic
symptoms. One way to increase the tests ability to relate to
swimmers with current asthma and other factors associated
with disease activity could thus be the use of reversibility
and/or variability as complementary test criteria. This was
most clearly shown for the mannitol provocation test where
the sensitivity for detecting current asthma, asthma with
exercise induced symptoms and rhinitis with impact on daily
living increased while the specificity decreased only slightly
or remained unchanged. The difference for the exercise
test was not as obvious. This can partly be explained by the
assumed lower sensitivity in our study with overall fewer
positive tests. There were no differences in the clinical
characteristics between the swimmers who were mannitol
or exercise positive and those who were reversible 15% in
the different tests. The swimmers positive in both tests
with extended criteria were the swimmers with most
pronounced symptoms. A much higher agreement between
the two tests was achieved when reversibility and/or vari-
ability were included in the criteria, and even more
pronounced among the swimmers with current asthma.
When only using ordinary criteria defined as a direct
bronchoconstricitve response either as PD15Mann or Exerc
10%, there is a high risk of not detecting patient with
clinically relevant asthma symptoms and missing the
patients who could benefit from a proper diagnosis and
treatment. In this age group there is a high risk of devel-
oping asthma and in our study we found a tendency for the
swimmers to misinterpret their symptoms. Despite that
several of the swimmers have asthmatic symptoms and
positive tests they did not report and understand that their
breathing difficulties were symptoms of asthma but thought
it was due to lesser physical fitness. Other swimmers re-
ported symptoms of asthma but had negative tests. For
eight of the swimmers this was probably due to their
regular treatment with inhaled corticosteroids (ICS).
There are several limitations with the study. We chose
not to do reversibility testing as this would have required an
extra visit. However all subjects had normal lung function
at baseline and thus it is less likely that a substantial
number would have been reversible if tested. Another
limitation is the lack of a control group that would have
allowed comparative studies. There is also a difficulty
concerning withdrawal of asthma medication when
studying elite athletes due to their rigorous training and
frequent competitions.
In clinical workwith athletes in terms of both exercise and
elite activities, it is important that we have the tools that are
sensitive enough to capture the asthmatics that would
benefit from asthma treatment. We also have to inform and
to educate the trainers and teachers so they are aware of the
different ways of expression of asthma related problems
since some of the athletes do not recognize the symptoms.
It is also important to capture those whose respiratorysymptoms are not due to asthma and to help them with
proper treatment. This area requires more research.
In this study the swimmers had a lower FENO than one
would expect regarding their sensitization rate and their
symptoms. This has earlier been reported in studies
including swimmers and an epithelial damage has been
discussed as a possible cause (20). Another explanation
could be that high FENO usually is associated with an
eosinophilic airway inflammation while swimmers have
been reported to have a more neutrophilic inflammation.27
In summary, using the ordinary criteria, there is a risk of
missing patients with asthma symptoms who could benefit
from a proper diagnosis and treatment. Using extended
criteria in the interpretation of the tests gives us greater
ability to detect asthma in elite swimmers while the
increased risk of misdiagnosis stays low.
A high number of our swimmers had one or two positive
challenge tests and the majority were symptomatic. This
clearly show that swimming at least in a chlorinated pool
environment is a definite risk factor for asthma develop-
ment. It is thus very important to carry out regular controls
of the pool environment and to reduce future risk exposure.Acknowledgements
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